CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-08 | Davidar David D Director | Exercise or conversion | +25,000 | $13.04 | $326K | 758,775 |
| 2018-03-08 | Davidar David D Director | Sale | −25,000 | $50.50 | $1.3M | 733,775 |
| 2018-03-08 | Davidar David D Director | Exercise or conversion | +30,000 | $23.95 | $719K | 763,775 |
| 2018-03-08 | Davidar David D Director | Sale | −30,000 | $50.50 | $1.5M | 733,775 |
| 2018-03-08 | Davidar David D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −15,000 | 0 | ||
| 2018-03-08 | Davidar David D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 0 | ||
| 2018-03-08 | Davidar David D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −30,000 | 0 | ||
| 2018-02-02 | Murphy A Brett EVP, International Sales | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2018-01-22 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | LIPTAK ROBERT Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | WHEELER KURT Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +25,000 | 25,000 | ||
| 2018-01-22 | Payne Steven Chief Accounting Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +7,500 | 7,500 | ||
| 2018-01-22 | Schwartz Eric Senior VP and General Counsel | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2018-01-22 | Scavilla Daniel T Senior VP and CFO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +80,000 | 80,000 | ||
| 2018-01-22 | Williams Anthony L President | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +80,000 | 80,000 | ||
| 2018-01-22 | Demski David M Chief Executive Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +150,000 | 150,000 | ||
| 2018-01-22 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 |
Page 28 of 36 · 710 trades